1. Home
  2. PLSE vs DXPE Comparison

PLSE vs DXPE Comparison

Compare PLSE & DXPE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLSE
  • DXPE
  • Stock Information
  • Founded
  • PLSE 2014
  • DXPE 1908
  • Country
  • PLSE United States
  • DXPE United States
  • Employees
  • PLSE N/A
  • DXPE N/A
  • Industry
  • PLSE Medical/Dental Instruments
  • DXPE Industrial Machinery/Components
  • Sector
  • PLSE Health Care
  • DXPE Industrials
  • Exchange
  • PLSE Nasdaq
  • DXPE Nasdaq
  • Market Cap
  • PLSE 1.0B
  • DXPE 828.9M
  • IPO Year
  • PLSE 2016
  • DXPE 1996
  • Fundamental
  • Price
  • PLSE $17.19
  • DXPE $49.76
  • Analyst Decision
  • PLSE
  • DXPE
  • Analyst Count
  • PLSE 0
  • DXPE 0
  • Target Price
  • PLSE N/A
  • DXPE N/A
  • AVG Volume (30 Days)
  • PLSE 182.4K
  • DXPE 103.7K
  • Earning Date
  • PLSE 08-12-2024
  • DXPE 11-06-2024
  • Dividend Yield
  • PLSE N/A
  • DXPE N/A
  • EPS Growth
  • PLSE N/A
  • DXPE 15.59
  • EPS
  • PLSE N/A
  • DXPE 3.54
  • Revenue
  • PLSE N/A
  • DXPE $1,684,484,000.00
  • Revenue This Year
  • PLSE N/A
  • DXPE $5.33
  • Revenue Next Year
  • PLSE N/A
  • DXPE $3.05
  • P/E Ratio
  • PLSE N/A
  • DXPE $14.06
  • Revenue Growth
  • PLSE N/A
  • DXPE 2.34
  • 52 Week Low
  • PLSE $3.78
  • DXPE $28.82
  • 52 Week High
  • PLSE $22.69
  • DXPE $57.38
  • Technical
  • Relative Strength Index (RSI)
  • PLSE 47.58
  • DXPE 45.14
  • Support Level
  • PLSE $16.56
  • DXPE $51.22
  • Resistance Level
  • PLSE $18.18
  • DXPE $54.10
  • Average True Range (ATR)
  • PLSE 1.75
  • DXPE 1.92
  • MACD
  • PLSE -0.44
  • DXPE -0.13
  • Stochastic Oscillator
  • PLSE 10.28
  • DXPE 12.99

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.

About DXPE DXP Enterprises Inc.

DXP Enterprises Inc is a distributor of products and services to industrial customers in the United States, Canada, Mexico, and Dubai. The company's reportable segments include Service Centers, Innovative Pumping Solutions and Supply Chain Services. It generates maximum revenue from the Service Centers segment. The company offers pumping solutions, supply chain services and maintenance, repair, operating and production services for rotating equipment, bearings and power transmissions, industrial supplies and safety products. DXP Enterprises serves the General Industrial, Oil & Gas, Food & Beverage, Water & Wastewater, Chemical, Transportation, Aerospace & Other.

Share on Social Networks: